What Happened
- US Treasury Secretary Scott Bessent stated that the tariff rates introduced by the Trump administration could be restored to their earlier levels by early July 2026, approximately five months after the US Supreme Court struck down much of the original tariff framework.
- In February 2026, the US Supreme Court ruled 6–3 that the International Emergency Economic Powers Act (IEEPA, 1977) does not authorise the President to impose tariffs, striking down sweeping "reciprocal tariffs" that had ranged up to 145% on Chinese goods and 25% on Indian goods.
- Following the Supreme Court ruling, the administration imposed a replacement 10% global tariff using a different statutory authority (Section 122 of the Trade Act of 1974), which is limited to 150 days.
- The administration also sought a 90-day pause on the Supreme Court ruling to enable orderly tariff refunds to businesses; this request was denied, and refunds were ordered.
- Bessent suggested that within the 150-day window, the administration expects to have a new legislative or executive mechanism to restore tariff rates to IEEPA-era levels, potentially through Congressional action.
Static Topic Bridges
IEEPA (International Emergency Economic Powers Act, 1977): Legal Architecture
IEEPA was enacted in 1977 by the US Congress as part of a broader reform of emergency economic powers, replacing the broader Trading with the Enemy Act (1917). It grants the US President sweeping authority to regulate international economic transactions — including trade, investment, and financial flows — after declaring a national emergency threatening national security, foreign policy, or the economy. The Trump administration invoked IEEPA in 2025 to impose "reciprocal tariffs" globally, arguing trade deficits constituted a national emergency. The US Supreme Court's 6–3 ruling in February 2026 determined that tariff imposition falls outside IEEPA's scope, as tariffs are a Congressional prerogative under Article I of the US Constitution.
- IEEPA enacted: 1977; applies to international emergencies (not domestic).
- US Constitution, Article I, Section 8: grants Congress the power to "lay and collect Taxes, Duties, Imposts and Excises" — tariff authority is constitutionally Congressional.
- Presidents can impose tariffs under specific statutes: Section 232 (Trade Expansion Act, 1962 — national security), Section 301 (Trade Act, 1974 — unfair trade practices), Section 201 (Trade Act, 1974 — safeguard/escape clause).
- Supreme Court ruling (February 2026): 6–3, IEEPA does not extend to tariff imposition.
Connection to this news: Bessent's statement signals the administration's intent to circumvent the Supreme Court ruling through alternative authority (Section 122) and eventually through new legislation, illustrating how executive-legislative-judicial separation of powers plays out in US trade policy — directly relevant to India's ongoing BTA negotiations and tariff exposure.
Section 122 Tariffs and the 150-Day Clock
Section 122 of the Trade Act of 1974 allows the US President to impose a temporary tariff surcharge of up to 15% for up to 150 days when the US faces a large and serious balance-of-payments deficit. It is rarely used and was designed as a short-term emergency tool. The Trump administration invoked Section 122 to impose a 10% global tariff as a replacement after the IEEPA tariffs were struck down. The 150-day limitation means this authority expires around July 2026 — hence Bessent's reference to "early July" as the timeline for restoration of higher tariff rates via new authority.
- Section 122 maximum tariff surcharge: 15%; maximum duration: 150 days.
- The 10% global tariff under Section 122 is significantly lower than the original IEEPA rates (25% on India, up to 145% on China).
- US Congress would need to legislate to give the President permanent tariff authority above Section 122 limits.
- India-US interim trade framework (February 2026): locked India's tariff at 18% — this framework rate may need to be re-confirmed under a new legal authority.
Connection to this news: The July 2026 deadline is critical for India-US trade negotiations. If higher tariff rates are restored, India's 18% rate under the interim framework could be superseded, creating uncertainty for Indian exporters — particularly in pharmaceuticals, textiles, and IT services.
Impact of US Tariffs on India: Trade Flows and Strategic Leverage
US tariffs directly affect Indian export competitiveness in the American market. India's major goods exports to the US include pharmaceuticals, engineering goods, textiles and apparel, gems and jewellery, and IT hardware. A tariff increase from 18% to higher levels would raise input costs for US importers of Indian goods, potentially reducing India's market share. However, in certain sectors — particularly generic pharmaceuticals — India has near-irreplaceable supply position (supplying ~40% of US generic drugs), giving India natural leverage. The broader US tariff regime also affects India indirectly: China-directed tariffs (145%) accelerate the "China+1" strategy, drawing manufacturing investments to India.
- India's goods exports to US (2023-24): approximately $78–80 billion; pharmaceuticals are the top category (~$8 billion).
- US pharmaceutical sector dependency on India: ~40% of generic drug supply — creates strategic negotiating leverage for India.
- China tariff rate under IEEPA: up to 145%; restoration of these rates would intensify Chinese goods redirection through third countries.
- GSP (Generalised System of Preferences): India was the largest beneficiary before the US withdrew India's GSP benefits in 2019 — not yet restored.
Connection to this news: The tariff restoration timeline is directly relevant to India's export planning. The uncertainty between the 10% Section 122 tariff and potential restoration of higher rates creates economic risk for Indian businesses and complicates the ongoing BTA negotiations.
Key Facts & Data
- US Supreme Court ruling on IEEPA tariffs: February 2026, 6–3 decision — IEEPA does not authorise tariff imposition.
- Replacement tariff: 10% global surcharge under Section 122, Trade Act 1974 — valid for 150 days (expires ~July 2026).
- Original IEEPA tariff on India: 25%, reduced to 18% under India-US interim framework (February 2026).
- IEEPA tariff on China: up to 145%.
- Bessent's timeline for tariff restoration: "within five months" from ruling (i.e., ~July 2026).
- IEEPA enacted: 1977 (replaced Trading with the Enemy Act, 1917).
- US Constitution, Article I, Section 8: Congressional authority over tariffs.
- India's goods exports to the US (2023-24): approximately $78–80 billion.
- India supplies ~40% of generic drugs in the US market.
- Section 122 maximum rate: 15%; Section 232 (national security): unlimited; Section 301 (unfair trade): up to 100%+.